Qvanteq
Z├╝rich, Zurich, Switzerland
About Qvanteq
Qvanteq is a medtech startup company, developing novel bioactive stents to address and overcome the clinical adverse effects of today’s available coronary and endovascular stents. Its bioactive Qstent controls in-growth therefore reducing the risk of restenosis and thrombosis. The company was awarded with the CTI start-up label in 2012. Qvanteq was founded in 2009 and is held by private investors. The ISO 13485 certified company is based in Zürich, Switzerland. It is a spin-off company from the Swiss Federal Institute of Technology, Zurich.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $4.4M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2013)
- Website: qvanteq.com
- Phone: 41 44 500 98 90
Industries & Categories
Biotechnology, Developer Platform, Medical
Social Profiles
Canonical: https://fsome.com/organization/qvanteq-2495601 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.